New Century Financial Group LLC Boosts Stake in Sanofi (NASDAQ:SNY)

New Century Financial Group LLC lifted its holdings in Sanofi (NASDAQ:SNY) by 62.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,309 shares of the company’s stock after buying an additional 3,201 shares during the quarter. New Century Financial Group LLC’s holdings in Sanofi were worth $403,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. POM Investment Strategies LLC acquired a new position in Sanofi during the second quarter worth $25,000. Register Financial Advisors LLC acquired a new position in Sanofi during the first quarter worth $29,000. Larson Financial Group LLC raised its holdings in Sanofi by 480.8% during the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after purchasing an additional 500 shares during the last quarter. Palisade Asset Management LLC acquired a new position in Sanofi during the first quarter worth $31,000. Finally, Arrow Financial Corp acquired a new position in Sanofi during the second quarter worth $35,000. 10.04% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

SNY has been the subject of several research reports. StockNews.com raised Sanofi from a “buy” rating to a “strong-buy” rating in a report on Wednesday. Argus boosted their price target on Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Finally, Citigroup raised Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. Three analysts have rated the stock with a hold rating, one has assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $57.50.

Sanofi Stock Performance

NASDAQ SNY opened at $57.31 on Wednesday. The stock has a market cap of $145.43 billion, a price-to-earnings ratio of 28.80, a price-to-earnings-growth ratio of 1.62 and a beta of 0.60. The business has a fifty day moving average of $55.31 and a 200-day moving average of $50.97. Sanofi has a fifty-two week low of $42.63 and a fifty-two week high of $58.97. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, July 25th. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.88 by $0.05. The firm had revenue of $10.75 billion during the quarter, compared to analyst estimates of $16.86 billion. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.95 earnings per share. As a group, analysts predict that Sanofi will post 4.26 earnings per share for the current fiscal year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.